- Advanced search
- Guide to IMMUNOPHARMACOLOGY Portal
Molecular properties generated using the CDK
|Compound class||Synthetic organic|
|JZL 195 | JZL-195|
|JZL195 was first reported as a dual inhibitor of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MGLL, a.k.a. MAGL) in 2009 . Animal experiments suggest that dual FAAH/MAGL inhibitiors may have improved analgesic effects against neuropathic pain, in comparison to selective FAAH and MAGL inhibitors, or cannabinoid receptor agonists [1-2,4,6].
JZL195 has since been reported to also inhibit acyloxyacyl hydrolase (AOAH) 
|CAS Registry No.||1210004-12-8 (source: PubChem)|
|GtoPdb PubChem SID||252166807|
|Search Google for chemical match using the InChIKey||QNYRAEKLMNDRFY-UHFFFAOYSA-N|
|Search Google for chemicals with the same backbone||QNYRAEKLMNDRFY|
|Search UniChem for chemical match using the InChIKey||QNYRAEKLMNDRFY-UHFFFAOYSA-N|
|Search UniChem for chemicals with the same backbone||QNYRAEKLMNDRFY|
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.✖
Cat. No. 4715